CNR2 and multiple sclerosis: AM9338, 1-(3-(1H-1,2,3-triazol-1-yl)propyl)-N-(adamantan-1-yl)-1H-indazole-3-carboxamide, is a potent and selective CB2 agonist (hCB2 Ki = 3 nM, mCB2 Ki = 2.3 nM), which was discovered at the Center for Drug Discovery at Northeastern University as a candidate for potential multiple Sclerosis treatment.